Vaccination

This section includes a series of trainings, guidelines, and a vaccine tracker developed by the World Health Organization to inform practitioners on the different vaccines available and how to participate in vaccination programs.

Guidelines

Key Things to Know About COVID-19 Vaccines
Information curated by the CDC on availability, safety, cost, and effectiveness of COVID-19 vaccines. 

  • Language: English, Español, 简体中文, Tiếng Việt, 한국어 
  • For: General population, Community Health Workers, Nurses, Physicians, Pharmacists, Respiratory Therapists, Healers, Hospital and Health Systems, Public Health Organizations 
  • Created by: CDC. Updated 6/25/2021 

WHO SAGE COVID Vaccines Advisory
The SAGE COVID Vaccine Advisory is a set of guidelines (general and specific information) by WHO that covers recommendations for usage of different vaccines along with information on evidence, framework, supply and allocation.

  • Language: English
  • For: General population, Community Health Workers, Nurses, Physicians, Pharmacists, Respiratory Therapists, Healers, Hospital and Health Systems, Public Health Organizations
  • Created by: WHO
  • Last updates for each vaccine:
    • Sinopharm COVID-19 vaccine BIBP – 5/7/21
    • Janssen Ad26.COV2.S (COVID-19) vaccine – 3/17/21
    • Astra Zeneca – Oxford University AZD1222 vaccine – 4/21/21
    • Moderna mRNA-1273 vaccine – 2/3/21
    • Pfizer – BioNTech BNT162b2 vaccine – 1/14/21

Addressing Vaccine Hesitancy

Teeka Lagwaya, Na?
Vaccination campaign developed by Dr. Brian Wahl (Johns Hopkins Bloomberg School of Public Health) and partners in India to address vaccine hesitancy.

Awareness of COVID-19 Vaccine among Indian Youth
8-minute video.

  • Languages: Marathi, with English subtitles
  • For: Community Health Workers, Nurses, Physicians, Hospital and Health Systems, Public Health Organizations
  • Created by: Lakshya, A Society for Public Health, Education and Research, Pune, India. Created: May 2021

Courses and Training Programs

COVID Vaccination Training
3-hour course, comprising short videos, lecture, quizzes, provides general and specific information about on-site vaccination: settings, preparedness, and response for adverse events.

  • Languages: English, Urdu
  • For: Community Health Workers, Nurses, Physicians, Respiratory Therapists, Hospital and Health Systems, Public Health Organizations
  • Created by: WHO

JHU COVID-19 Vaccination Training Program
1.5-hour training for preparing to participate in COVID-19 vaccination programs.

  • Language: English
  • For: Community Health Workers, Nurses, Physicians, Respiratory Therapists, Healers, Hospital and Health Systems, Public Health Organizations
  • Created by: Johns Hopkins University

CDC: COVID-19 Vaccination Training Programs
A series of trainings on storing, handling, preparing, and administering COVID-19 vaccinations

  • Language: English
  • For: Community Health Workers, Nurses, Physicians, Respiratory Therapists, Hospital and Health Systems, Public Health Organizations
  • Created by: CDC

Webinars

COVID-19 Vaccine Safety: Spotlight on the AstraZeneca and Johnson & Johnson Vaccines
1-hour webinar

  • Language: English
  • For: Nurses, Physicians, Respiratory Therapists, Hospital and Health Systems, Public Health Organizations
  • Created by: Johns Hopkins Division of Infectious Diseases. Hosted by the Johns Hopkins Center for Clinical Global Health Education. Updated: 4/27/2021

SARS-CoV-2 Variants: Evolution, Implications, and Vaccines

  • 1-hour webinar
  • Language: English
  • For: Nurses, Physicians, Respiratory Therapists, Hospital and Health Systems, Public Health Organizations
  • Created by: Johns Hopkins Division of Infectious Diseases. Hosted by the Johns Hopkins Center for Clinical Global Health Education. Updated: 2/23/2021

COVID-19 Vaccines and the Rise of AntiScience
1-hour webinar

  • Last updated: 2/23/2021
  • Language: English
  • For: Community Health Workers, Nurses, Physicians, Respiratory Therapists, Hospital and Health Systems, Public Health Organizations
  • Created by: Johns Hopkins Division of Infectious Diseases. Hosted by the Johns Hopkins Center for Clinical Global Health Education. Updated: 2/23/2021

Addressing challenges in vaccination in fragile contexts
1.5-hour webinar

  • Language: English
  • For: Community Health Workers, Nurses, Physicians, Respiratory Therapists, Hospital and Health Systems, Public Health Organizations
  • Created by: Johns Hopkins University International Vaccine Access Center. Updated 5/21/2021

Engaging civil society to support equitable access to COVID-19 vaccines
1-hour webinar: Leaders in the international health field discuss the importance of engaging civil service organizations with vaccination activities, especially in LMICs, to advance access, including the COVAX initiative.

  • Language: English
  • For: General population, Community Health Workers, Nurses, Physicians, Respiratory Therapists, Healers, Hospital and Health Systems, Public Health Organizations
  • Created by: Johns Hopkins University International Vaccine Access Center. Updated 10/20/2020

Research

WHO COVID-19 Vaccine Development Tracker
Detailed information on COVID-19 vaccine candidates in development

  • Language: English
  • For: General population, Community Health Workers, Nurses, Physicians, Respiratory Therapists, Healers, Hospital and Health Systems, Public Health Organizations
  • Created by: WHO. Updated 6/07/2021

JHU Novel Coronavirus Research Compendium: Vaccines
Reviews of data on safety, immunogenicity, efficacy, and effectiveness of vaccine candidates targeting SARS-CoV-2

  • Language: English
  • For: Nurses, Physicians, Respiratory Therapists, Hospital and Health Systems, Public Health Organizations
  • Created by: Johns Hopkins University Novel Coronavirus Research Compendium. Updated: 6/17/2021

The New York Times Vaccination Tracker
Includes monitoring of vaccine administration in India.

  • Continuously updated
  • Language: English
  • For: General population, Community Health Workers, Nurses, Physicians, Respiratory Therapists, Healers, Hospital and Health Systems, Public Health Organizations
  • Created by: The New York Times. Updated 5/27/2021

Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
A research study examining the safety and efficacy of single-dose AD26.COV2.S vaccine against COVID-19. A single dose of Ad26.COV2.S protected against symptomatic Covid-19 and asymptomatic SARS-CoV-2 infection and was effective against severe–critical disease, including hospitalization and death. Safety appeared to be similar to that in other phase 3 trials of Covid-19 vaccines. Created by: Jerald Sadoff, et al. The New England Journal of Medicine 

  • Last Updated: 6/10/2021 
  • Language: English 
  • Aimed at: Nurses, Physicians, Respiratory Therapists, Hospital and Health Systems 

Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons
A research study examining the safety of mRNA COVID-19 vaccines in pregnant persons. Preliminary findings did not show obvious safety signals among pregnant persons who received mRNA Covid-19 vaccines. However, more longitudinal follow-up, including follow-up of large numbers of women vaccinated earlier in pregnancy, is necessary to inform maternal, pregnancy, and infant outcomes.

  • Language: English 
  • For: Nurses, Physicians, Respiratory Therapists, Hospital and Health Systems, Public Health Organizations 
  • Created by: Tim T. Shimabukuro, et al. The New England Journal of Medicine. Updated 6/17/2021 

Vaccine Breakthrough Infections with SARS-CoV-2 Variants
A research study examining whether individuals who had received the second dose of the Pfizer-BioNTech or Moderna vaccines would show signs of illnesses if infected with a variant of the COVID-19 virus. In a cohort of 417 persons who had received either of the second dose at least 2 weeks previously, 2 women were identified with vaccine breakthrough infection. These observations indicate a potential risk of illness after successful vaccination and subsequent infection with variant virus, and they provide support for continued efforts to prevent and diagnose infection and to characterize variants in vaccinated persons.

  • Language: English 
  • Aimed at: Nurses, Physicians, Respiratory Therapists, Hospital and Health Systems, Public Health Organizations 
  • Created by: Ezgi Hacisuleyman, et al. The New England Journal of Medicine. Updated 6/10/2021 

*The resources for this section were reviewed by Johns Hopkins University students Khushbu Balsara, Snehal Ghodke, and Vanya Prasad, Research Associate Noor Zanial, and Faculty Dr. Brian Wahl on behalf of the Johns Hopkins India Institute COVID-19 Task Force Technical Working Group.